These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29764463)

  • 1. LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
    Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
    J Exp Clin Cancer Res; 2018 May; 37(1):105. PubMed ID: 29764463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
    Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
    J Exp Clin Cancer Res; 2018 Jun; 37(1):121. PubMed ID: 29925408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
    Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
    Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
    Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
    Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
    Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.
    Chen ZZ; Huang L; Wu YH; Zhai WJ; Zhu PP; Gao YF
    Nat Commun; 2016 Aug; 7():12598. PubMed ID: 27553854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis.
    Chen Z; Yao L; Liu Y; Zhu P
    Cancer Lett; 2018 Aug; 430():88-96. PubMed ID: 29778568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.
    Fu X; Lin J; Qin F; Yang Z; Ding Y; Zhang Y; Han L; Zhu X; Zhang Q
    Mol Carcinog; 2018 Mar; 57(3):408-418. PubMed ID: 29144570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
    Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
    Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling.
    Wang Y; He L; Du Y; Zhu P; Huang G; Luo J; Yan X; Ye B; Li C; Xia P; Zhang G; Tian Y; Chen R; Fan Z
    Cell Stem Cell; 2015 Apr; 16(4):413-25. PubMed ID: 25842979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N
    Chen Z; Huang L; Wang K; Zhang L; Zhong X; Yan Z; Liu B; Zhu P
    Sci China Life Sci; 2022 Sep; 65(9):1840-1854. PubMed ID: 35266112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling.
    Wu J; Zhu P; Lu T; Du Y; Wang Y; He L; Ye B; Liu B; Yang L; Wang J; Gu Y; Lan J; Hao Y; He L; Fan Z
    J Hepatol; 2019 May; 70(5):918-929. PubMed ID: 30582981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF.
    Chen Z; Lu T; Huang L; Wang Z; Yan Z; Guan Y; Hu W; Fan Z; Zhu P
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34403373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N
    Gu C; Wang Z; Zhou N; Li G; Kou Y; Luo Y; Wang Y; Yang J; Tian F
    Mol Cancer; 2019 Nov; 18(1):168. PubMed ID: 31760940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
    Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
    Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling.
    Wang Y; Zhu P; Luo J; Wang J; Liu Z; Wu W; Du Y; Ye B; Wang D; He L; Ren W; Wang J; Sun X; Chen R; Tian Y; Fan Z
    EMBO J; 2019 Sep; 38(17):e101110. PubMed ID: 31334575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.
    Yang S; Ruan X; Hu B; Tu J; Cai H
    Cell Tissue Res; 2023 Dec; 394(3):441-453. PubMed ID: 37851112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
    Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
    J Exp Clin Cancer Res; 2019 Dec; 38(1):500. PubMed ID: 31861994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.